159 related articles for article (PubMed ID: 38466946)
1. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
3. Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner.
Song Y; Lian S; Fan H; Ma C; Zheng L; Huang F; Huang S; Tang Y; Shi A; Shu L; Zhao L; Xu Y; Guo S; Liu Z; Zhang Z
Cancer Lett; 2024 Jun; 592():216921. PubMed ID: 38705565
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
6. A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.
Liang S; Guo H; Ma K; Li X; Wu D; Wang Y; Wang W; Zhang S; Cui Y; Liu Y; Sun L; Zhang B; Xin M; Zhang N; Zhou H; Liu Y; Wang J; Liu L
Cancer Res; 2021 Dec; 81(23):5889-5903. PubMed ID: 34580062
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.
Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L
J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
10. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
[TBL] [Abstract][Full Text] [Related]
12. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
[TBL] [Abstract][Full Text] [Related]
14. Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma.
Roy S; Kumaravel S; Banerjee P; White TK; O'Brien A; Seelig C; Chauhan R; Ekser B; Bayless KJ; Alpini G; Glaser SS; Chakraborty S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831316
[TBL] [Abstract][Full Text] [Related]
15. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
16. COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma.
Lang Q; Xiao P; Zhao M; Liang D; Meng Q; Pei T
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1247-1256. PubMed ID: 33166992
[TBL] [Abstract][Full Text] [Related]
17. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
[TBL] [Abstract][Full Text] [Related]
20. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]